lobbying_activities: 2508437

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2508437	d6aa502f-70d7-400c-bc99-0f8d6b7fc514	Q3	ROCK & ASSOCIATES	33545	WOMEN'S INTERNATIONAL PHARMACY	2020	third_quarter	PHA	H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	11250		0	0	2020-10-14T23:50:41.707000-04:00